US Stock MarketDetailed Quotes

CHRO Chromocell Therapeutics

Watchlist
  • 0.630
  • -0.001-0.16%
Close Nov 18 16:00 ET
  • 0.630
  • 0.0000.00%
Post 16:03 ET
3.80MMarket Cap-364P/E (TTM)

Chromocell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.57%2.05M
126.99%1.76M
111.46%1.93M
196.02%6.86M
219.29%3.88M
148.96%1.29M
161.97%777.16K
217.73%914.58K
176.30%2.32M
478.57%1.21M
Selling and administrative expenses
31.47%1.63M
140.80%1.75M
101.43%1.47M
122.32%4.28M
72.20%1.58M
153.15%1.24M
169.25%727.21K
197.03%728.47K
205.81%1.93M
513.86%920.23K
-General and administrative expense
31.47%1.63M
140.80%1.75M
101.43%1.47M
122.32%4.28M
72.20%1.58M
153.15%1.24M
169.25%727.21K
197.03%728.47K
205.81%1.93M
513.86%920.23K
Research and development costs
743.93%414.64K
-74.07%12.96K
150.71%466.61K
558.47%2.58M
678.80%2.29M
75.59%49.13K
87.99%49.96K
336.97%186.12K
87.39%391.73K
390.50%294.58K
Operating profit
-58.57%-2.05M
-126.99%-1.76M
-111.46%-1.93M
-196.02%-6.86M
-219.29%-3.88M
-148.96%-1.29M
-161.97%-777.16K
-217.73%-914.58K
-176.30%-2.32M
-478.57%-1.21M
Net non-operating interest income expense
69.99%-39.02K
93.72%-11.06K
-1,108.87%-628.35K
-269.23%-518.51K
-276.27%-160.34K
-243.82%-130.01K
-371.08%-176.19K
-129.94%-51.98K
-55,405.93%-140.43K
-42.61K
Non-operating interest expense
-69.99%39.02K
-93.72%11.06K
1,108.87%628.35K
269.23%518.51K
276.27%160.34K
243.82%130.01K
371.08%176.19K
129.94%51.98K
55,405.93%140.43K
--42.61K
Other net income (expense)
392.7K
3.53K
Special income (charges)
--363.09K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
---363.09K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
--29.61K
--3.53K
----
----
----
----
----
----
----
----
Income before tax
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Net income continuous Operations
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Minority interest income
Net income attributable to the parent company
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Basic earnings per share
-17.64%-0.29
-87.54%-0.31
-428.45%-0.55
-383.39%-1.2797
-417.24%-0.7003
-311.25%-0.2465
-359.53%-0.1653
-246.93%-0.1041
-156.45%-0.2647
-498.87%-0.1354
Diluted earnings per share
-17.64%-0.29
-87.54%-0.31
-428.45%-0.55
-383.39%-1.2797
-417.24%-0.7003
-311.25%-0.2465
-359.53%-0.1653
-246.93%-0.1041
-156.45%-0.2647
-498.87%-0.1354
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 58.57%2.05M126.99%1.76M111.46%1.93M196.02%6.86M219.29%3.88M148.96%1.29M161.97%777.16K217.73%914.58K176.30%2.32M478.57%1.21M
Selling and administrative expenses 31.47%1.63M140.80%1.75M101.43%1.47M122.32%4.28M72.20%1.58M153.15%1.24M169.25%727.21K197.03%728.47K205.81%1.93M513.86%920.23K
-General and administrative expense 31.47%1.63M140.80%1.75M101.43%1.47M122.32%4.28M72.20%1.58M153.15%1.24M169.25%727.21K197.03%728.47K205.81%1.93M513.86%920.23K
Research and development costs 743.93%414.64K-74.07%12.96K150.71%466.61K558.47%2.58M678.80%2.29M75.59%49.13K87.99%49.96K336.97%186.12K87.39%391.73K390.50%294.58K
Operating profit -58.57%-2.05M-126.99%-1.76M-111.46%-1.93M-196.02%-6.86M-219.29%-3.88M-148.96%-1.29M-161.97%-777.16K-217.73%-914.58K-176.30%-2.32M-478.57%-1.21M
Net non-operating interest income expense 69.99%-39.02K93.72%-11.06K-1,108.87%-628.35K-269.23%-518.51K-276.27%-160.34K-243.82%-130.01K-371.08%-176.19K-129.94%-51.98K-55,405.93%-140.43K-42.61K
Non-operating interest expense -69.99%39.02K-93.72%11.06K1,108.87%628.35K269.23%518.51K276.27%160.34K243.82%130.01K371.08%176.19K129.94%51.98K55,405.93%140.43K--42.61K
Other net income (expense) 392.7K3.53K
Special income (charges) --363.09K------------------0----------------
-Less:Other special charges ---363.09K------------------------------------
Other non- operating income (expenses) --29.61K--3.53K--------------------------------
Income before tax -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Income tax 0000000000
Net income -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Net income continuous Operations -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Minority interest income
Net income attributable to the parent company -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Basic earnings per share -17.64%-0.29-87.54%-0.31-428.45%-0.55-383.39%-1.2797-417.24%-0.7003-311.25%-0.2465-359.53%-0.1653-246.93%-0.1041-156.45%-0.2647-498.87%-0.1354
Diluted earnings per share -17.64%-0.29-87.54%-0.31-428.45%-0.55-383.39%-1.2797-417.24%-0.7003-311.25%-0.2465-359.53%-0.1653-246.93%-0.1041-156.45%-0.2647-498.87%-0.1354
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data